Holdings

Paradigm Biocapital Advisors LP

As of Sep 30, 2026, Paradigm Biocapital Advisors LP reported 29 positions worth US$5.01B. Largest: Revolution Medicines, Inc., Genmab A/S and Edgewise Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Revolution Medicines, Inc.6.22MUS$1.28B−142KSep 30, 2026
Genmab A/S14.1MUS$504M+1MSep 30, 2026
Edgewise Therapeutics, Inc.10.8MUS$438M+563KSep 30, 2026
Spyre Therapeutics, Inc.4.46MUS$397M+617KSep 30, 2026
Insmed Incorporated2.7MUS$308M+1.37MSep 30, 2026
MBX Biosciences, Inc.3.77MUS$221M+1.26MSep 30, 2026
Oruka Therapeutics, Inc.2.49MUS$208M+349KSep 30, 2026
Belite Bio, Inc.1.14MUS$194MnewSep 30, 2026
Tarsus Pharmaceuticals, Inc.2.3MUS$181M−474KSep 30, 2026
Tango Therapeutics, Inc.6.96MUS$174M+604KSep 30, 2026